Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Development of new in vitro methods for frontloading of reproductive toxicology in drug development

Reference number
Coordinator AstraZeneca AB - AstraZeneca R&D Södertälje
Funding from Vinnova SEK 4 050 000
Project duration August 2008 - March 2012
Status Completed

Last updated 25 November 2019

Reference number 2008-00139

Page statistics